Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial

Chemokine receptor CCR5: from AIDS to atherosclerosis

(2010) KL Jones et al.   BRITISH JOURNAL OF PHARMACOLOGY

Genetic Association of the CCR5 Region With Lipid Levels in At-Risk Cardiovascular Patients

(2010) Craig L. Hyde et al.   Circulation-Cardiovascular Genetics

Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes

(2010) R. Krysiak et al.   DIABETES CARE

Atorvastatin Causes Insulin Resistance and Increases Ambient Glycemia in Hypercholesterolemic Patients

(2010) Kwang Kon Koh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Metabolic Syndrome and Cardiovascular Risk

(2010) Salvatore Mottillo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Monocytes in atherosclerosis: subsets and functions

(2010) Kevin J. Woollard et al.   Nature Reviews Cardiology

Inhibition of the chemokine (C–C motif) ligand 2/chemokine (C–C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy

(2009) S. J. Yang et al.   DIABETOLOGIA

Glucocorticoids and Thiazolidinediones Interfere with Adipocyte-mediated Macrophage Chemotaxis and Recruitment

(2009) David Patsouris et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Macrophage inflammatory protein-1β induced cell adhesion with increased intracellular reactive oxygen species

(2009) Yuji Tatara et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Comparison Effect of Atorvastatin (10 versus 80 mg) on Biomarkers of Inflammation and Oxidative Stress in Subjects With Metabolic Syndrome

(2008) Uma Singh et al.   AMERICAN JOURNAL OF CARDIOLOGY

Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease

(2008) Ignatios Ikonomidis et al.   ATHEROSCLEROSIS

CC Chemokine and CC Chemokine Receptor Profiles in Visceral and Subcutaneous Adipose Tissue Are Altered in Human Obesity

(2008) Joakim Huber et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Effect of Atorvastatin in Patients with Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Study

(2008) Thozhukat Sathyapalan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Signal-activated phospholipase regulation of leukocyte chemotaxis: Fig. 1.

(2008) Martha K. Cathcart   JOURNAL OF LIPID RESEARCH

Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults

(2008) Christina L. Aquilante et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE